Unusual 11 Mid-Day Movers 12/04: (CYCC) (BIG) (GALE) Higher; (UEPS) (GERN) (CUR) Lower
Tweet
Share
E-mail
Get Alerts UEPS Hot Sheet
Join SI Premium – FREE
Net 1 Ueps Technologies Inc. (Nasdaq: UEPS) 56.8% LOWER; under a probe by the FBI and U.S.DOJ over dealings in South Africa.
Geron Corp (Nasdaq: GERN) 25.0% LOWER; announced that the company has discontinued development of GRN1005, its peptide-drug conjugate designed to treat cancers in the brain. Click here for more color.
Neuralstem (AMEX: CUR) 21.5% LOWER; popping higher on a Crain's Business article discussing positive results from the company's stem-cell injections. For more, click here.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) 13.6% LOWER; investors taking profits after shares more than doubled over the last few weeks.
Neutral Tandem, Inc. (Nasdaq: IQNT) 17.4% LOWER; saw a little bit of insider activity disclosed late Monday night. Check out the filings here.
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) 16.2% HIGHER; announced that updated Phase 3 clinical trial results for the treatment of elderly patients with newly diagnosed acute myeloid leukemia (AML) treated with sapacitabine and decitabine administered in alternating cycles will be presented at a poster presentation during the 54th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, on Sunday, December 9, 2012.
Big Lots, Inc. (NYSE: BIG) 14.2% HIGHER; reported Q3 EPS of ($0.10), $0.14 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.14 billion. Comparable store sales for U.S. stores open at least fifteen months decreased 4.6% for the quarter. Sees Q4 2012 EPS of $1.91-$2.10, versus the consensus of $2.02. Also sees FY2012 EPS of $2.86-$3.05, compared with Street expectations of $2.80.
Galena Biopharma, Inc. (Nasdaq: GALE) 12.1% HIGHER; has signed an agreement with a subsidiary of Teva Pharmaceutical Industries Limited (NYSE: TEVA) for the commercialization of NeuVax™ (nelipepimut-S or E75) in Israel.
Education Management Corporation (Nasdaq: EDMC) 13.6% HIGHER; market sentiment moving above the key $4 price level today.
Pacer Int'l (Nasdaq: PACR) 11.1% HIGHER; higher following a positive mention by Reuters earlier in relation to cashing in on the Mexico trade boom. Some insiders also disclosed recent trades, click here for more.
Young Innovations, Inc. (Nasdaq: YDNT) 9.4% HIGHER; entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners for $39.50 per share.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Geron Corp (Nasdaq: GERN) 25.0% LOWER; announced that the company has discontinued development of GRN1005, its peptide-drug conjugate designed to treat cancers in the brain. Click here for more color.
Neuralstem (AMEX: CUR) 21.5% LOWER; popping higher on a Crain's Business article discussing positive results from the company's stem-cell injections. For more, click here.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) 13.6% LOWER; investors taking profits after shares more than doubled over the last few weeks.
Neutral Tandem, Inc. (Nasdaq: IQNT) 17.4% LOWER; saw a little bit of insider activity disclosed late Monday night. Check out the filings here.
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) 16.2% HIGHER; announced that updated Phase 3 clinical trial results for the treatment of elderly patients with newly diagnosed acute myeloid leukemia (AML) treated with sapacitabine and decitabine administered in alternating cycles will be presented at a poster presentation during the 54th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, on Sunday, December 9, 2012.
Big Lots, Inc. (NYSE: BIG) 14.2% HIGHER; reported Q3 EPS of ($0.10), $0.14 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.14 billion. Comparable store sales for U.S. stores open at least fifteen months decreased 4.6% for the quarter. Sees Q4 2012 EPS of $1.91-$2.10, versus the consensus of $2.02. Also sees FY2012 EPS of $2.86-$3.05, compared with Street expectations of $2.80.
Galena Biopharma, Inc. (Nasdaq: GALE) 12.1% HIGHER; has signed an agreement with a subsidiary of Teva Pharmaceutical Industries Limited (NYSE: TEVA) for the commercialization of NeuVax™ (nelipepimut-S or E75) in Israel.
Education Management Corporation (Nasdaq: EDMC) 13.6% HIGHER; market sentiment moving above the key $4 price level today.
Pacer Int'l (Nasdaq: PACR) 11.1% HIGHER; higher following a positive mention by Reuters earlier in relation to cashing in on the Mexico trade boom. Some insiders also disclosed recent trades, click here for more.
Young Innovations, Inc. (Nasdaq: YDNT) 9.4% HIGHER; entered into a definitive agreement to be acquired by an affiliate of Linden Capital Partners for $39.50 per share.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Media & Technology Group (DJT) send letter to Nasdaq over “naked” short selling
- Esquire Financial (ESQ) Files $100M Mixed Shelf
- Redwoods Acquisition (RWOD) stockholders approve proposals
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
